Director/PDMR Shareholding

AI SummaryClose X

Hikma Pharmaceuticals PLC announced that several Persons Discharging Managerial Responsibility (PDMRs) received ordinary shares on June 1, 2026, due to the vesting of conditional awards under the 2023 Long-Term Incentive Plan (LTIP) and the 2014 Executive Incentive Plan (EIP) Element C. Specifically, Said Darwazah received 91,812 LTIP shares and 19,761 EIP shares, Mazen Darwazah received 72,763 LTIP shares and 20,650 EIP shares, Khalid Nabilsi received 51,650 LTIP shares and 22,209 EIP shares, Bassam Kanaan received 52,640 LTIP shares and 20,982 EIP shares, and Hussein Arkhagha received 28,631 LTIP shares and 12,406 EIP shares. All these individuals retained their shares. In contrast, Susan Ringdal sold 38,222 shares, comprising 26,558 LTIP and 11,664 EIP shares, at a price of £14.49 per share, totaling £553,748.83.

Disclaimer*

UK 100

Latest directors dealings